Prelude Therapeutics shares owned by OrbiMed Advisors
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by OrbiMed Advisors
from 13F filings
Historical chart of OrbiMed Advisors investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by OrbiMed Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $23M | 11M | 2.07 |
| 2024-06-30 | $42M | 11M | 3.81 |
| 2024-03-31 | $52M | 11M | 4.74 |
| 2023-12-31 | $47M | 11M | 4.27 |
| 2023-09-30 | $34M | 11M | 3.09 |
| 2023-06-30 | $49M | 11M | 4.50 |
| 2023-03-31 | $57M | 10M | 5.70 |
| 2022-12-31 | $61M | 10M | 6.04 |
| 2022-09-30 | $66M | 10M | 6.61 |
| 2022-06-30 | $52M | 10M | 5.22 |
| 2022-03-31 | $69M | 10M | 6.90 |
| 2021-12-31 | $125M | 10M | 12.45 |
| 2021-09-30 | $314M | 10M | 31.25 |
| 2021-06-30 | $287M | 10M | 28.63 |
| 2021-03-31 | $435M | 10M | 43.33 |
| 2020-12-31 | $1.1B | 16M | 71.55 |
| 2020-09-30 | $470M | 16M | 30.13 |